Regulators recently scolded the France-based pharmaceutical firm for safety issues that occurred at its plant in Raleigh, North Carolina, which produces imaging contrast agents. 

Dubbed "Gail's Law" after a breast cancer care advocate, the passage follows years of advocacy from radiologists and patients. 

The system is designed for point-of-care settings such as outpatient offices, sports medicine practices and urgent care clinics.

In a Final Rule revealed last week, the Centers for Medicare & Medicaid Services outlined its plan to exchange medical records, diagnostic images and clinical notes electronically using secure protocols. Once the rule is published in the Federal Register, any HIPAA-covered entity that interacts with Medicare will have two years to follow CMS into the modern age.

ImmunityBio, the developer of bladder cancer treatment Anktiva, is accused by the U.S. Food and Drug Administration of disseminating “false or misleading information” about the drug's efficacy in an advertisement and podcast. The FDA said it’s not the first time it's sent a warning letter to the company’s executives over allegedly inaccurate claims.

U.S. healthcare will know it’s gotten AI right when the technology demonstrably improves care access, attentiveness and outcomes for the least financially healthy among us. 

Several U.S. medical societies have collaborated on a new report advocating for better safety standards in cardiac catheterization labs. As one cardiologist described it, clinicians have shifted from "accepting risk" to "expecting better."

Under the final rule, the agency would establish national standards for the electronic exchange of images and other clinical documentation.